mianserin has been researched along with oxidopamine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Nakamura, S | 2 |
| Enna, SJ; Pilc, A | 1 |
| Duman, RS; Enna, SJ | 1 |
| Brus, R; Kalbfleisch, JH; Kostrzewa, RM; Plech, A | 1 |
| Deutch, AY; Fitzgerald, LW; Gasic, G; Heinemann, SF; Nestler, EJ | 1 |
| Bouvard, M; Rénéric, JP; Stinus, L | 1 |
| Di Chiara, G; Frau, R; Valentini, V | 1 |
| Grasso, SA; Holtz, NA; Napier, TC; Persons, AL; Tedford, SE | 1 |
1 review(s) available for mianserin and oxidopamine
| Article | Year |
|---|---|
Axonal sprouting of noradrenergic locus coeruleus neurons following repeated stress and antidepressant treatment.
Topics: Animals; Antidepressive Agents; Axons; Chronic Disease; Desipramine; Electroconvulsive Therapy; Electrophysiology; Female; Immersion; Locus Coeruleus; Maprotiline; Mianserin; Models, Neurological; Nerve Regeneration; Neuronal Plasticity; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Stimulation, Chemical; Stress, Physiological | 1991 |
9 other study(ies) available for mianserin and oxidopamine
| Article | Year |
|---|---|
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Effects of mianserin and fluoxetine on axonal regeneration of brain catecholamine neurons.
Topics: Adrenergic alpha-Antagonists; Animals; Axons; Cerebral Cortex; Denervation; Fluoxetine; Mianserin; Nerve Regeneration; Neurotransmitter Uptake Inhibitors; Norepinephrine; Oxidopamine; Rats; Serotonin | 1991 |
Supersensitive beta-adrenergic receptors are down-regulated in rat brain by mianserin administration.
Topics: 5,7-Dihydroxytryptamine; Animals; Brain; Cerebral Cortex; Cyclic AMP; Hydroxydopamines; Isoproterenol; Male; Mianserin; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Serotonin | 1987 |
beta-Adrenergic receptor regulation and antidepressants: the influence of adrenocorticotropin.
Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Cerebral Cortex; Cyclic AMP; Desipramine; Dihydroalprenolol; Hydroxydopamines; Imipramine; Male; Mianserin; Oxidopamine; Pargyline; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1983 |
Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Corpus Striatum; Female; Mianserin; Motor Activity; Mouth; Oxidopamine; Piperazines; Rats; Rats, Inbred Strains; Serotonin Receptor Agonists | 1995 |
Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Benzazepines; Cerebral Cortex; Clozapine; Corpus Striatum; Dopamine; Dopamine Antagonists; Gene Expression Regulation; Haloperidol; Humans; Limbic System; Male; Mesencephalon; Mianserin; Models, Neurological; Oxidopamine; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Salicylamides; Schizophrenia; Serotonin; Substantia Nigra | 1995 |
In the rat forced swimming test, NA-system mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Biogenic Monoamines; Brain; Depression; Dopamine Agents; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Immobilization; Male; Mianserin; Mirtazapine; Motor Activity; Norepinephrine; Oxidopamine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Swimming | 2002 |
Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine.
Topics: Analysis of Variance; Animals; Cerebral Cortex; Clozapine; Desipramine; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Extracellular Space; Male; Mianserin; Microdialysis; Morpholines; Neural Pathways; Norepinephrine Plasma Membrane Transport Proteins; Oxidopamine; Piperazines; Rats; Rats, Sprague-Dawley; Reboxetine; Serotonin Antagonists; Symporters; Time Factors | 2004 |
Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease.
Topics: Animals; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Benzothiazoles; Corpus Striatum; Delay Discounting; Dopamine Agonists; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Mianserin; Mirtazapine; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pramipexole; Random Allocation; Rats, Sprague-Dawley; Risk-Taking; Self Stimulation | 2016 |